EULAV Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-67,000
| Closed | -$5.3M | – | 289 |
|
2016
Q3 | $5.3M | Sell |
67,000
-8,000
| -11% | -$633K | 0.28% | 128 |
|
2016
Q2 | $6.26M | Sell |
75,000
-41,000
| -35% | -$3.42M | 0.34% | 102 |
|
2016
Q1 | $10.7M | Buy |
116,000
+6,000
| +5% | +$551K | 0.59% | 57 |
|
2015
Q4 | $11.1M | Buy |
110,000
+1,000
| +0.9% | +$101K | 0.61% | 56 |
|
2015
Q3 | $10.7M | Buy |
109,000
+14,000
| +15% | +$1.37M | 0.61% | 60 |
|
2015
Q2 | $11.1M | Buy |
95,000
+1,000
| +1% | +$117K | 0.58% | 61 |
|
2015
Q1 | $9.22M | Buy |
94,000
+2,000
| +2% | +$196K | 0.48% | 80 |
|
2014
Q4 | $8.67M | Sell |
92,000
-1,000
| -1% | -$94.3K | 0.47% | 83 |
|
2014
Q3 | $9.9M | Buy |
93,000
+27,000
| +41% | +$2.87M | 0.54% | 63 |
|
2014
Q2 | $5.47M | Buy |
66,000
+10,000
| +18% | +$829K | 0.29% | 119 |
|
2014
Q1 | $3.97M | Sell |
56,000
-7,000
| -11% | -$496K | 0.22% | 159 |
|
2013
Q4 | $4.73M | Sell |
63,000
-24,000
| -28% | -$1.8M | 0.26% | 140 |
|
2013
Q3 | $5.47M | Sell |
87,000
-5,000
| -5% | -$314K | 0.32% | 105 |
|
2013
Q2 | $4.71M | Buy |
+92,000
| New | +$4.71M | 0.29% | 123 |
|